|
EP0633943A4
(en)
|
1992-04-03 |
1997-05-02 |
Alexander T Young |
GENTHERAPY USING TARGETED VIRAL VECTORS.
|
|
US5849589A
(en)
|
1996-03-11 |
1998-12-15 |
Duke University |
Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
US9840695B2
(en)
|
2009-04-28 |
2017-12-12 |
Agriculture Victoria Services Pty Ltd |
Plant technology
|
|
GB201004551D0
(en)
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
|
|
GB201423361D0
(en)
|
2014-12-30 |
2015-02-11 |
Immatics Biotechnologies Gmbh |
Method for the absolute Quantification of naturally processed HLA-Restricted cancer peptides
|
|
GB201504502D0
(en)
|
2015-03-17 |
2015-04-29 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
|
|
GB201505305D0
(en)
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
GB201505585D0
(en)
|
2015-03-31 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers
|
|
GB201507719D0
(en)
|
2015-05-06 |
2015-06-17 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
|
|
GB201510771D0
(en)
|
2015-06-19 |
2015-08-05 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer
|
|
GB201511191D0
(en)
|
2015-06-25 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
T-cell epitopes for the immunotherapy of myeloma
|
|
GB201511546D0
(en)
|
2015-07-01 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
|
GB201511792D0
(en)
|
2015-07-06 |
2015-08-19 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against esopageal cancer and other cancers
|
|
MY189596A
(en)
|
2015-07-15 |
2022-02-18 |
Immatics Biotechnologies Gmbh |
A novel peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
|
|
GB201513921D0
(en)
|
2015-08-05 |
2015-09-23 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
|
|
US10335471B2
(en)
|
2015-08-28 |
2019-07-02 |
Immatics Biotechnologies Gmbh |
Method for treating cancer with activated T cells
|
|
GB201517538D0
(en)
|
2015-10-05 |
2015-11-18 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
|
|
HK1258444A1
(zh)
|
2015-10-09 |
2019-11-15 |
Immatics Biotechnologies Gmbh |
抗wt1/hla特异性抗体
|
|
GB201521746D0
(en)
|
2015-12-10 |
2016-01-27 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers
|
|
GB201521894D0
(en)
|
2015-12-11 |
2016-01-27 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against various cancers
|
|
GB201522667D0
(en)
|
2015-12-22 |
2016-02-03 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
|
|
GB201602918D0
(en)
|
2016-02-19 |
2016-04-06 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against NHL and other cancers
|
|
GB201603568D0
(en)
|
2016-03-01 |
2016-04-13 |
Immatics Biotechnologies Gmbh |
Efficient treatment options including peptides and combination of peptide and cell based medicaments for use in immunotherapy against urinary bladder cancer
|
|
GB201603987D0
(en)
|
2016-03-08 |
2016-04-20 |
Immatics Biotechnologies Gmbh |
Uterine cancer treatments
|
|
GB201604494D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Transfected T-Cells and T-Cell receptors for use in immunotherapy against cancers
|
|
GB201604492D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Transfected t-cells and t-cell receptors for use in immunotherapy against cancers
|
|
GB201604458D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against cancers
|
|
NZ746387A
(en)
|
2016-03-16 |
2022-08-26 |
Immatics Biotechnologies Gmbh |
Transfected t-cells and t-cell receptors for use in immunotherapy against cancers
|
|
CN116731156A
(zh)
|
2016-03-16 |
2023-09-12 |
伊玛提克斯生物技术有限公司 |
用于癌症免疫治疗的转染t细胞和t细胞受体
|
|
ZA201900664B
(en)
|
2016-08-17 |
2021-09-29 |
Paul Ehrlich Strasse 15 Tuebingen 72076 Germany |
T cell receptors and immune therapy using the same
|
|
DE102016115246C5
(de)
|
2016-08-17 |
2018-12-20 |
Immatics Biotechnologies Gmbh |
Neue t-zellrezeptoren und deren verwendung in immuntherapie
|
|
CN109996868A
(zh)
*
|
2016-09-23 |
2019-07-09 |
弗雷德哈钦森癌症研究中心 |
特异性用于次要组织相容性(h)抗原ha-1的tcr及其用途
|
|
EP3300863B1
(en)
|
2016-09-28 |
2020-06-17 |
Braun GmbH |
Electric shaver
|
|
DE102016123893A1
(de)
|
2016-12-08 |
2018-06-14 |
Immatics Biotechnologies Gmbh |
T-Zellrezeptoren mit verbesserter Bindung
|
|
KR20240007775A
(ko)
|
2016-12-08 |
2024-01-16 |
이매틱스 바이오테크놀로지스 게엠베하 |
T 세포 수용체 및 이를 사용하는 면역 요법
|
|
DE102016123859B3
(de)
|
2016-12-08 |
2018-03-01 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie
|
|
DE102016123847B3
(de)
|
2016-12-08 |
2018-04-05 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie
|
|
DE102017106305A1
(de)
|
2017-03-23 |
2018-09-27 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapien gegen prame-positive Krebsarten
|
|
US11236145B2
(en)
|
2017-03-23 |
2022-02-01 |
Immatics Biotechnologies Gmbh |
T cell receptors and immune therapy using the same against PRAME positive cancers
|
|
WO2018189148A1
(en)
|
2017-04-10 |
2018-10-18 |
Immatics Biotechnologies Gmbh |
Peptides and combination thereof for use in the immunotherapy against cancers
|
|
EA201992416A1
(ru)
|
2017-04-10 |
2020-02-25 |
Имматикс Байотекнолоджиз Гмбх |
Пептиды и комбинации пептидов для применения в иммунотерапии лейкозов и других видов рака
|
|
DE102017114737A1
(de)
|
2017-06-30 |
2019-01-03 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie
|
|
LT3428194T
(lt)
|
2017-07-14 |
2021-12-10 |
Immatics Biotechnologies Gmbh |
Pagerinta dvejopo savitumo polipeptido molekulė
|
|
DE102017212608B4
(de)
|
2017-07-21 |
2023-11-16 |
Ford Global Technologies, Llc |
Radnaben-Einheit mit Wärmedämmbeschichtung zur Reduzierung der thermischen Belastung eines Radlagers
|
|
KR20250052472A
(ko)
|
2017-11-06 |
2025-04-18 |
이매틱스 바이오테크놀로지스 게엠베하 |
신규 조작된 t 세포 수용체 및 이를 사용하는 면역 요법
|
|
DE102017127984B4
(de)
|
2017-11-27 |
2019-12-05 |
Immatics US, Inc. |
Verfahren für die Vermehrung und Aktivierung von γδ-T-Zellen
|
|
DE102018100967B4
(de)
|
2018-01-17 |
2019-08-14 |
Immatics US, Inc. |
Verfahren zur feststellung der wirksamkeit von viralen vektoren
|
|
BR112020016176A2
(pt)
|
2018-02-09 |
2022-02-22 |
Immatics Us Inc |
Métodos de transdução de uma célula t, célula t transduzida geneticamente, composição farmacêutica, métodos de preparação de uma população de células t e uso da célula t
|
|
DE102018107224A1
(de)
|
2018-02-21 |
2019-08-22 |
Immatics Biotechnologies Gmbh |
Peptide und Kombinationen von Peptiden nicht-kanonischen Ursprungs zur Verwendung in der Immuntherapie gegen verschiedene Krebsarten
|
|
DE102018108612A1
(de)
|
2018-03-21 |
2019-09-26 |
Immatics US, Inc. |
Verfahren zur erhöhung der persistenz von adoptiv infundierten t-zellen
|
|
CA3097396A1
(en)
*
|
2018-04-19 |
2019-10-24 |
Baylor College Of Medicine |
Reprogramming cd4 t cells into cytotoxic cd8 cells by forced expression of cd8ab and class 1 restricted t cell receptors
|
|
DE102018122546B3
(de)
|
2018-09-14 |
2019-12-05 |
Immatics Biotechnologies Gmbh |
Verfahren zum Hochdurchsatz-Peptid-MHC-Affinitätsscreening für TCR-Liganden
|
|
WO2020185796A1
(en)
*
|
2019-03-11 |
2020-09-17 |
Fred Hutchinson Cancer Research Center |
High avidity wt1 t cell receptors and uses thereof
|
|
WO2020243134A1
(en)
*
|
2019-05-27 |
2020-12-03 |
Immatics US, Inc. |
Viral vectors and their use in adoptive cellular therapy
|
|
US12011459B2
(en)
|
2019-06-06 |
2024-06-18 |
Immatics US, Inc. |
Methods for manufacturing T cells by direct sorting and compositions thereof
|
|
DE102020111571A1
(de)
|
2020-03-11 |
2021-09-16 |
Immatics US, Inc. |
Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
|